Why the study?
Recent continuous evolutions in ultrasound have introduced innovative echocardiographic modalities that can better evaluate morphofunctional abnormalities in ischemic heart disease.
New echocardiographic modalities offer promising applications for the diagnosis, risk stratification, and monitoring of patients with ischemic heart disease during cardiac rehabilitation.
Should not yet change rehabilitation protocols; hypothesis-generating and requires prospective validation trials.
Owing to its ease of application, noninvasive nature, and safety, echocardiography is an essential imaging modality to assess cardiac function in patients affected by ischemic heart disease (IHD). Over the past few decades, we have witnessed a continuous series of evolutions in the ultrasound field that have led to the introduction of innovative echocardiographic modalities which allowed to better understand the morphofunctional abnormalities occurring in cardiovascular diseases. This article offers an overview of some of the newest echocardiographic modalities and their promising application in IHD diagnosis, risk stratification, management, and monitoring after cardiac rehabilitation.
No takes yet. Share an insight, caveat, or question.
D’Andrea et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: